Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model
Authors:
- 1 May 2011
- journal article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 12 (5) , 717-725
Abstract
Objective. Intrathecally administered fentanyl rarely causes drug tolerance or formation of inflammatory masses and might therefore be a suitable treatment option for chronic pain. However, the neurotoxicity of intrathecally administered fentanyl remains to be clarified. We examined the histological changes, neurodysfunction, and side effects of intrathecal fentanyl in rats. Design. The rats received fentanyl at 0.12 µL/g body weight (0, 50, 1,000, 2,000, and 5,000 µg/mL in saline) via an intrathecal catheter. Seven days after the injection, the spinal cord with both roots were removed for histological examination. The neurological function was evaluated by monitoring walking behavior and latencies to radiant heat. Side effects were also recorded. Results. No histological abnormalities were observed in the spinal cord, anterior and posterior roots, cauda equina nerves, or arachnoid membrane. Formation of white neomembrane was noted around the catheter in some animals, but there was no significant difference in the incidence among the groups. The sensory threshold was significantly higher at 1 and 2 hours after injection in the 50 and 5,000 µg/mL groups, respectively. However, there was no significant difference in the sensory threshold among the five groups at 7 days postinjection. All of the rats walked normally within 4 hours even after injection of 5,000 µg/mL fentanyl. The incidence of apnea, muscular rigidity, and bradycardia increased significantly at ≥1,000 µg/mL dose. Conclusions. The side effects of intrathecally administered fentanyl were concentration-dependent, although no neuronal tissue damage, inflammation, or irreversible neurodysfunction were observed even at 5,000 µg/mL.Keywords
This publication has 14 references indexed in Scilit:
- Management of Intrathecal Catheter-Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert PanelNeuromodulation: Technology at the Neural Interface, 2008
- A Review of Intrathecal Fentanyl and Sufentanil for the Treatment of Chronic PainPain Medicine, 2006
- Neurotoxicity of Intrathecally Administered Bupivacaine Involves the Posterior Roots/Posterior White Matter and Is Milder Than Lidocaine in RatsRegional Anesthesia & Pain Medicine, 2005
- Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective studyPain, 2004
- Inflammatory Masses Associated with Intrathecal Drug Infusion: A Review of Preclinical Evidence and Human DataPain Medicine, 2002
- Major Complications of Regional Anesthesia in FranceAnesthesiology, 2002
- Neurotoxicity of Intrathecally Administered Tetracaine Commences at the Posterior Roots Near Entry Into the Spinal CordRegional Anesthesia & Pain Medicine, 2000
- Reexamination of C. elegans as a Model System for the Study of Volatile Anesthetic MechanismsAnesthesiology, 1994
- Behavioral and Histopathologic Effects Following Intrathecal Administration of Butorphanol, Sufentanil, and Nalbuphine in SheepAnesthesiology, 1991
- VASOPRESSIN-INDUCED MYOCARDIAL ISCHEMIA AND REVERSAL WITH A SPECIFIC ANTAGONISTAnesthesiology, 1986